DEF 14A: The Joint Corp Aims for Chiropractic Dominance: Refranchising Strategy and 2024 Incentive Plan Unveiled

The Joint Corp outlines its strategic vision to champion chiropractic care through refranchising, brand elevation, and a new incentive stock plan.

Summary

• The Joint Corp is focused on becoming the 'Champions of Chiropractic' by expanding access to affordable, membership-based services.
• In 2023, the company achieved growth in system-wide sales, revenue, Adjusted EBITDA, patient visits, and patients treated.
• The Joint surpassed 900 units opened in August 2023, a milestone achieved by only 3.4% of franchise systems.
• The company expanded to 41 states and the District of Columbia, ending the year with 935 clinics.
• Key performance indicators for 2023 include 13.6 million patient visits, 1.7 million unique patients, and over 932,000 new patients.
• Approximately 36% of new patients had never visited a chiropractor before.
• Membership revenue accounted for 85% of system-wide gross sales.
• Revenue increased by 16% to $117.7 million, and system-wide sales grew by 12% to $488.0 million.
• The company reported a net loss of $9.8 million, including a $10.8 million non-cash valuation allowance, compared to a net income of $627,000 in the prior year.
• Adjusted EBITDA increased by 6% to $12.2 million.
• The Joint began implementing a refranchising strategy in late 2023 to optimize operations and enhance stockholder value.
• The company plans to sell the vast majority of its corporate clinic portfolio, prioritizing existing franchisees.
• The goal is to unlock capital for brand marketing, RD territory acquisitions, and potential stock repurchases.
• The company estimates that Americans spend $20.5 billion on chiropractic care annually, with $8.5 billion spent out-of-pocket.
• The Joint spent over $35 million in 2023 on marketing to educate consumers about chiropractic care.
• The company is seeking stockholder approval for the 2024 Incentive Stock Plan to continue granting equity-based awards.
• The maximum number of shares of common stock for which awards may be granted under the 2024 Plan is 2,000,000 shares.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While there's positive growth in sales and patient visits, the net loss and refranchising strategy introduce uncertainty. The company's strong market position and future plans offer some optimism.

Positives

• The Joint Corp achieved growth in system-wide sales, revenue, Adjusted EBITDA, patient visits, and patients treated in 2023.
• The company has a strong franchise model with approximately 85% recurring revenue.
• The Joint is the category creator and leader in the out-of-pocket chiropractic care segment.
• The company is implementing a refranchising strategy to unlock capital and improve profitability.
• The Joint has a strong brand and a large digital footprint, attracting many new patients.

Negatives

• The company reported a net loss of $9.8 million in 2023, including a $10.8 million non-cash valuation allowance.
• The document mentions 'ongoing uncertainties in our patient demographic' which may be a cause for concern.

Risks

• The refranchising strategy may not be successful if the company cannot find suitable franchisees or if the terms of the sales are unfavorable.
• The company's performance is subject to economic conditions and consumer spending patterns.
• Competition in the chiropractic care market may increase.
• The company's ability to attract and retain qualified doctors and wellness coordinators is critical to its success.
• The company's marketing efforts may not be effective in attracting new patients or retaining existing ones.

Future Outlook

The company aims to drive total systems sales by increasing new patient counts and optimizing sales per patient, evaluating opportunities for line extensions and ancillary products, and fortifying its franchise base.

Management Comments

• Advancing The Joint's Vision to be the Champions of Chiropractic.
• Leveraging Robust Foundation to Drive Sustainable, Profitable Growth.
• Our refranchising strategy is driven by a commitment to maximizing stockholder value while positioning our clinics for sustainable growth and success.

Industry Context

The Joint Corp operates in the $20.5 billion chiropractic care industry, focusing on the $8.1 billion out-of-pocket segment. The company estimates that its clinic count exceeds the aggregate of all other franchised chiropractic concepts.

Comparison to Industry Standards

• The Joint Corp's franchise model, with approximately 85% recurring revenue, is a strong indicator of financial health compared to other franchise systems.
• The company's growth in system-wide sales and patient visits demonstrates its ability to capture market share in the competitive chiropractic care industry.
• The Joint's FUND score of 910 out of 950 from FRANdata is significantly higher than the average of 593, indicating a strong investment quality.

Related Party Transactions

• Mr. Jefferson Gramm, Managing Partner of Bandera Partners LLC who is a beneficial holder of more than 5% of our outstanding common stock (approximately 27% as of December 31, 2023) was appointed to the Board of Directors effective as of January 2, 2024, to serve until the election and qualification of his successor at the 2024 Annual Meeting.
• In December 2020, we sold two franchise licenses at $39,900 and $29,900 each (which reflects the $10,000 multi-unit discount for the second license per the Franchise Disclosure Document) to Mr. Marshall Gramm, who is a family member of Mr. Jefferson Gramm.
• In April 2020 and 2021, we sold two franchise licenses at $39,900 and $29,900, respectively (which reflects the $10,000 multi-unit discount for the second license per the Franchise Disclosure Document), to a franchisee of which Mr. Jefferson Gramm is a 50% co-partner in the business.
• In October 2020, Mr. Gramm loaned approximately $370,000 to an unaffiliated franchisee that owns and operates one franchise clinic.

Stakeholder Impact

• Shareholders: The refranchising strategy aims to maximize stockholder value.
• Franchisees: Existing franchisees are prioritized in the refranchising process.
• Employees: The company is committed to attracting, developing, and retaining a diverse and engaged workforce.
• Patients: The company aims to improve the quality of life for patients by providing expanded access to chiropractic services.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will continue to implement its refranchising strategy and provide updates on its progress.
• The company will focus on elevating its brand, strengthening its team, and enhancing its performance.

Key Dates

Keywords

chiropractic, franchise, refranchising, EBITDA, sales, patients, marketing, incentive plan, clinics, revenue